0001562180-18-003130.txt : 20180629 0001562180-18-003130.hdr.sgml : 20180629 20180629162219 ACCESSION NUMBER: 0001562180-18-003130 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180627 FILED AS OF DATE: 20180629 DATE AS OF CHANGE: 20180629 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Robbins Andrew R CENTRAL INDEX KEY: 0001590157 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-16633 FILM NUMBER: 18929546 MAIL ADDRESS: STREET 1: C/O 3200 WALNUT ST CITY: BOULDER STATE: CO ZIP: 80301 FORMER NAME: FORMER CONFORMED NAME: Robbins Andrews R DATE OF NAME CHANGE: 20131025 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ARRAY BIOPHARMA INC CENTRAL INDEX KEY: 0001100412 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 841460811 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 3200 WALNUT STREET CITY: BOULDER STATE: CO ZIP: 80301 BUSINESS PHONE: 3033816600 MAIL ADDRESS: STREET 1: 3200 WALNUT STREET CITY: BOULDER STATE: CO ZIP: 80301 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2018-06-27 false 0001100412 ARRAY BIOPHARMA INC ARRY 0001590157 Robbins Andrew R C/O ARRAY BIOPHARMA INC. 3200 WALNUT ST BOULDER CO 80301 false true false false COO Common Stock 2018-06-27 4 M false 32068.00 0.00 A 191535.00 D Common Stock 2018-06-27 4 F false 14104.00 18.50 D 177431.00 D Common Stock 2018-06-27 4 S false 17964.00 17.74 D 159467.00 D Restricted Stock Units 0.00 2018-06-27 4 M false 32068.00 0.00 D 2018-08-18 Common Stock 32068.00 0.00 D Represents shares released on vesting of Restricted Stock Units ("RSUs") granted to the reporting person on August 18, 2014. The grant of these RSUs was previously reported on Table II. Represents shares withheld to satisfy tax withholding obligations of the reporting person. These trades were made pursuant to a Rule 10b5-1 trading plan. The price reported for these shares is the weighted average sale price of transactions made at prices from $17.60 to $17.84. Details of actual prices for shares sold are available from the Issuer upon request. RSUs representing 32,068 shares of common stock vested upon the achievement of a second milestone relating to the return of rights to binimetinib to the Issuer on or prior to the fourth anniversary of the grant date, subject to continued service with the Issuer as of the vesting date. Jason Haddock, attorney-in-fact for Andrew R. Robbins 2018-06-29